Hepatitis C Pharmacotherapy

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 36
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2019-03-08T01:00:10-05:00",
  "meta" : {
    "versionId" : "41",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "AGA Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: Antiviral pharmacotherapy.),(Data Element Scope: Hepatitis C Pharmacotherapy.),(Inclusion Criteria: This value set should only include TTY SCD and GPCK that are human and prescribable.\n\nNon-pegylated and pegylated Interferon alpha-2a and -2b. Specific nucleoside analogues, RNA polymerase inhibitors and virus protease inhibitors used in Hepatitis C therapy, regardless of Hepatitis C virus genotype.),(Exclusion Criteria: )",
  "name" : "HepatitisCPharmacotherapy",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1099048",
      "display" : "peginterferon alfa-2b 0.3 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1099054",
      "display" : "peginterferon alfa-2b 0.6 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1099058",
      "display" : "peginterferon alfa-2b 0.2 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1102132",
      "display" : "boceprevir 200 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1102280",
      "display" : "telaprevir 375 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1232574",
      "display" : "interferon alfa-2b 18000000 UNT Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1298334",
      "display" : "{28 (ribavirin 200 MG Oral Tablet) / 28 (ribavirin 400 MG Oral Tablet) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1484916",
      "display" : "sofosbuvir 400 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1591943",
      "display" : "ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1720878",
      "display" : "interferon alfa-2b 10000000 UNT Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "204445",
      "display" : "interferon alfa-2b 6000000 UNT/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "248109",
      "display" : "ribavirin 200 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "248112",
      "display" : "ribavirin 40 MG/ML Oral Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "284192",
      "display" : "peginterferon alfa-2b 0.05 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "284193",
      "display" : "peginterferon alfa-2b 0.08 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "284194",
      "display" : "peginterferon alfa-2b 0.12 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "284195",
      "display" : "peginterferon alfa-2b 0.15 MG Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "311078",
      "display" : "interferon alfa-2b 50000000 UNT Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312817",
      "display" : "ribavirin 200 MG Oral Capsule",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "312818",
      "display" : "ribavirin 20 MG/ML Inhalation Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351270",
      "display" : "1 ML peginterferon alfa-2a 0.18 MG/ML Injection",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "545289",
      "display" : "interferon alfa-2b 10000000 UNT/ML Injectable Solution",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "597718",
      "display" : "ribavirin 400 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "597722",
      "display" : "ribavirin 600 MG Oral Tablet",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "731326",
      "display" : "0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "754738",
      "display" : "{28 (ribavirin 400 MG Oral Tablet) / 28 (ribavirin 600 MG Oral Tablet) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "757597",
      "display" : "{56 (ribavirin 600 MG Oral Tablet) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "757599",
      "display" : "{56 (ribavirin 400 MG Oral Tablet) } Pack",
      "version" : "05062024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "790286",
      "display" : "ribavirin 500 MG Oral Tablet",
      "version" : "05062024"
    } ],
    "total" : 29,
    "identifier" : "urn:uuid:986eac45-9864-4ca7-879b-65a30e2d6006",
    "timestamp" : "2024-06-14T10:34:39-04:00"
  },
  "title" : "Hepatitis C Pharmacotherapy",
  "extension" : [ {
    "valueString" : "PCPI Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-06-03",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2019-03-08",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "retired",
  "id" : "2.16.840.1.113762.1.4.1056.85",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.85",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1056.85"
  } ],
  "version" : "20190308"
}